FDA — authorised 3 March 1995
- Application: NDA020281
- Marketing authorisation holder: JANSSEN PHARMS
- Local brand name: ULTRAM
- Indication: TABLET — ORAL
- Status: approved
FDA authorised escitalopram and tramadol on 3 March 1995
Yes. FDA authorised it on 3 March 1995.
JANSSEN PHARMS holds the US marketing authorisation.